MG Motor India has taken strong measures to combat the impact of COVID-19 on its customers. Recently they partnered with Singapore-based Medklinn to explore natural sterilization of cabin air and surfaces in their cars. They plan to evaluate the viability of installing Cerafusion ™, Medklinn’s patented cabin sterilization technology in MG Hector and ZS EV.
Cerafusion ™ technology ensures the health and well-being of passengers by enabling complete disinfection and sterilization of the car’s cabin. It leverages active oxygen to sterilize allergens, pollutants, and microbial organisms thus eliminating bacteria, mould, yeast, and viruses from the air within the cabin, and sterilizing its own surfaces.
“As part of our commitment to innovation and safety, we are partnering with Medklinn, one of the top global players in this domain, to explore world-class cabin sterilization solution in our vehicles. We are pro-actively looking to deploy HVAC system-based cabin sterilization and disinfection technology. We will continue to work towards developing safer mobility experiences and services for our customers while providing them with a cleaner and safer in-car environment. As a future-forward brand, this initiative also highlights our readiness for the ‘new normal’ in the post-pandemic world,” commented Rajeev Chaba, President, and Managing Director – MG Motor India.
With this latest initiative, MG Motor plans to focus on staying ahead of the market’s evolutionary curve as an industry pioneer and tech leader through a proactive, agile, and innovation-led approach. The association with Medklinn is a way to ensure the highest levels of safety and well-being of its customers.